A carregar...
Nonspecific Interstitial Pneumonitis after Bortezomib and Thalidomide Treatment in a Multiple Myeloma Patient
Bortezomib, an inhibitor of 26S proteosome, is recently approved treatment option for multiple myeloma. Thalidomide, a drug with immunomodulating and antiangiogenic effects, has also shown promise as an effective treatment in multiple myeloma. Pulmonary complications are believed to be rare, especia...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Yonsei University College of Medicine
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2852803/ https://ncbi.nlm.nih.gov/pubmed/20376900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2010.51.3.448 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|